Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States and operates primarily in North America. Founded in 1987, Noven has established itself as a pioneer in transdermal drug delivery systems, focusing on innovative therapies for various medical conditions. The company’s core products include a range of transdermal patches that deliver medications effectively and conveniently, setting them apart in the market. Noven's commitment to research and development has led to significant milestones, including partnerships with major pharmaceutical companies to enhance treatment options. With a strong market position, Noven Pharmaceuticals continues to be recognised for its contributions to patient care, making strides in the development of unique therapeutic solutions that improve adherence and outcomes for patients.
DitchCarbon Score
How does Noven Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Noven Pharmaceuticals, Inc.'s score of 26 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Noven Pharmaceuticals, Inc.'s reported carbon emissions
Noven Pharmaceuticals, Inc., headquartered in the US, currently does not have available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing greenhouse gas emissions, often setting science-based targets to align with global climate goals. However, Noven's current stance on these initiatives remains unspecified.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Noven Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
